Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma

Current Cancer Drug Targets

Volumn 12, Issue 2, 2012, Pages 97-106

  Al Wadei, H A N ^a,b   Al Wadei, M H ^a   Ullah, M F ^a   Schuller, H M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b SANA A UNIVERSITY   (Yemen)

Author keywords

GABA; Intervention study; nAChR drug target; Nicotine; NSCLC; Smoking; Xenografts

Indexed keywords

4 AMINOBUTYRIC ACID; CORTISONE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; NICOTINIC RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL FRACTIONATION; CONTROLLED STUDY; GROWTH REGULATION; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; RISK FACTOR; SECOND MESSENGER; SIGNAL TRANSDUCTION; TREATMENT DURATION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; GAMMA-AMINOBUTYRIC ACID; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NICOTINE; RECEPTORS, NICOTINIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856430018     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800912799095171     Document Type: Article

References (51)

1. Bunn, P. A. J.; Thatcher, N. Systemic treatment for advanced (Stage IIIB/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusions. Oncologist 2008, 13, 37-46.
2. Devesa, S. S.; Bray, F.; Vizcaino, A. P.; Parkin, D. M. International lung cancer trends by histologic type: Male: Female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer 2005, 117, 294-299.
3. Schuller, H. M. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat. Rev. Cancer 2009, 9, 195-205.
4. Schuller, H. M.; Orloff, M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung Cancer Cells. Biochem. Pharmacol. 1998, 55, 1377-1384.
5. Arredondo, J.; Chernyavsky, A. I.; Grando, S. A. Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol. Ther. 2006, 5, 511-517.
6. Grozio, A.; Paleari, L.; Catassi, A.; Servent, D.; Cilli, M.; Piccardi, F.; Paganuzzi, M.; Cesario, A.; Granone, P.; Mourier, G.; Russo, P. Natural agents targeting the alpha7-nicotinicreceptor in NSCLC: A promising prospective in anti-cancer drug development. Int. J. Cancer 2008, 122, 1911-1915.
7. Koukourakis, G.; Zacharias, G. Nicotine has implications in different tumors types. Expert's eye making a literature analysis. J. BUON. 2011, 16, 210-214.
8. Wu, J. C.; Chruscinski, A.; De Jesus Perez, V. A.; Singh, H.; Pitsiouni, M.; Rabinovitch, M.; Utz, P. J.; Cooke, J. P. Cholinergic modulation of angiogenesis: Role of the 7 nicotinic acetylcholine receptor. J. Cell Biochem. 2009, 108, 433-446.
9. Lindstrom, J.; Anand, R.; Gerzanich, V.; Peng, X.; Wang, F.; Wells, G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 1996, 109, 125-137.
10. Wessler, I.; Kirkpatrick, C. J. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br. J. Pharmacol. 2008, 154, 1558-1571.
11. Improgo, M. R.; Tapper, A. R.; Gardner, P. D. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem. Pharmacol. 2011, 82, 1015-1021.
12. Tournier, J. M.; Birembaut, P. Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr. Opin. Oncol. 2011, 23, 83-87.
13. Improgo, M. R.; Scofield, M. D.; Tapper, A. R.; Gardner, P. D. From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene 2010, 29, 4874-4884.
14. Markou, A. Review. Neurobiology of Nicotine dependence. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2008, 363, 3159-3168.
15. Marks, M. J.; Pauly, J. R.; Gross, S. D.; Deneris, E. S.; Hermans-Borgmeyer, I.; Heinemann, S. F.; Collins, A. C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 1992, 12, 2765-2784.
16. Kawai, H.; Berg, D. K. Nicotinic acetylcholine receptors containing alpha 7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure. J. Neurochem. 2001, 78, 1367-78.
17. Wong, H. P.; Yu, L.; Lam, E. K.; Tai, E. K.; Wu, W. K.; Cho, C. H. nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymesmediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol. Appl. Pharmacol. 2007, 221, 261-267.
18. Hoffman, B. B.; Lefkowitz, R. J. Catecholamines and sympathomimetic drugs. In The Pharmacological Basis of Therapeutics, 8th edition; Godman Gilman A., Rall T. W. et al., Eds.; Pergamon Press: New York, 1990, pp. 187-220.
19. Palm, D.; Lang, K.; Niggemann, B.; Drell, T. L. T.; Masur, K.; Zaenker, K. S.; Entschladen, F. The Norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int. J. Cancer 2006, 118, 2744-2749.
20. Sood, A. K.; Bhatty, R.; Kamat, A. A.; Landen, C. N.; Han, L.; Thaker, P. H.; Li, Y.; Gershenson, D. M.; Lutgendorf, S.; Cole, S. W. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 2006, 12, 369-375.
21. Al-Wadei, H. A.; Plummer, H. K., 3rd; Schuller, H. M. Nicotine stimulates pancreatic cancer Xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis 2009, 30, 506-511.
22. Schuller, H. M.; Tithof, P. K.; Williams, M.; Plummer, H., 3rd. The Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-Butanone is a Beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via Beta-adrenergic receptor-mediated release of Arachidonic Acid. Cancer Res. 1999, 59, 4510-4515.
23. Al-Wadei, H. A.; Majidi, M.; Tsao, M. S.; Schuller, H. M. Low concentrations of beta-carotene stimulate the proliferation of human pancreatic duct epithelial cells in a PKA-dependent manner. Cancer Genomics Proteomics 2007, 4, 35-42.
24. Al-Wadei, H. A.; Schuller, H. M. Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J. Pathol. 2009, 218, 437-445.
25. Schuller, H. M.; Al-Wadei, H. A.; Majidi, M. Gammaaminobutyric acid, a potential tumor suppressor for small airwayderived lung adenocarcinoma. Carcinogenesis 2008, 29, 1979-1985.
26. Al-Wadei, H. A.; Al-Wadei, M. H.; Masi, T.; Schuller, H. M. Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells. Lung Cancer 2010, 69, 33-39.
27. Lawson, G. M.; Hurt, R. D.; Dale, L. C.; Offord, K. P.; Croghan, I. T.; Schroeder, D. R.; Jiang, N. S. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J. Clin. Pharmacol. 1998, 38, 502-509.
28. Dzimiri, N.; Basco, C.; Moorji, A.; Afrane, B.; Al-Halees, Z. Characterization of lymphocyte beta 2-adrenoceptor signaling in patients with left ventricular volume overload disease. Clin. Exp. Pharmacol. Physiol. 2002, 29, 181-188.
29. Giaccone, G.; Zucali, P. A. Src as a potential therapeutic target in non-small-cell lung cancer. Ann. Oncol. 2008, 19, 1219-1223.
30. Balsara, B. R.; Pei, J.; Mitsuuchi, Y.; Page, R.; Klein-Szanto, A.; Wang, H.; Unger, M.; Testa, J. R. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis 2004, 25, 2053-2059.
31. Schuller, H. M. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by Nicotine and tobacco-related Nitrosamines. Biochem. Pharmacol. 1989, 38, 3439-3442.
32. Maneckjee, R.; Minna, J. D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 3294-3298.
33. Al-Wadei, H. A.; Schuller, H. M. Beta-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma. Eur. J. Cancer 2009, 45, 1257-1264.
34. Masur, K.; Niggemann, B.; Zanker, K. S.; Entschladen, F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001, 61, 2866-2869.
35. Drell, T. L. T.; Joseph, J.; Lang, K.; Niggemann, B.; Zaenker, K. S.; Entschladen, F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res. Treat. 2003, 80, 63-70.
36. Sato, M.; Vaughan, M. B.; Girard, L.; Peyton, M.; Lee, W.; Shames, D. S.; Ramirez, R. D.; Sunaga, N.; Gazdar, A. F.; Shay, J. W.; Minna, J. D. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 Bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 2006, 66, 2116-2128.
37. Changeux, J.P. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat. Rev. Neurosci. 2010, 11, 389-401.
38. Fu, X. W.; Lindstrom, J.; Spindel, E. R. Nicotine activates and up-regulates nicotinic acetylcholine receptors in bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 2009, 41, 93-99.
39. Davis, R.; Rizwani, W.; Banerjee, S.; Kovacs, M.; Haura, E.; Coppola, D.; Chellappan, S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 2009, 4, e7524.
40. Dasgupta, P.; Rizwani, W.; Pillai, S.; Davis, R.; Banerjee, S.; Hug, K.; Lloyd, M.; Coppola, D.; Haura, E.; Chellappan, S.P. ARRB1-mediated regulation of E2F target genes in nicotineinduced growth of lung tumors. J. Natl. Cancer Inst. 2011, 103, 317-333.
41. Whalen, E.J.; Rajagopal, S.; Lefkowitz, R. J. Therapeutic potential of β-arrestin-and G protein-biased agonists. Trends Mol. Med. 2011, 17, 126-139.
42. Joseph, J.; Niggemann, B.; Zaenker, K. S.; Entschladen, F. The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res. 2002, 62, 6467-6469.
43. Takehara, A.; Hosokawa, M.; Eguchi, H.; Ohigashi, H.; Ishikawa, O.; Nakamura, Y.; Nakagawa, H. Gammaaminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res. 2007, 67, 9704-9712.
44. B Receptor. Cesk. Fysiol. 2004, 53, 117-124.
45. Bown, A. W.; Macgregor, K. B.; Shelp, B. J. Gammaaminobutyrate: Defense against invertebrate pests? Trends Plant Sci. 2006, 11, 424-427.
46. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768-780.
47. Gupta, S. C.; Kim, J. H.; Prasad, S.; Aggarwal, B. B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010, 29, 405-434.
48. Pereira, G. E.; Gaudillere, J. P.; Pieri, P.; Hilbert, G.; Maucourt, M.; Deborde, C.; Moing, A.; Rolin, D. Microclimate influence on mineral and metabolic profiles of grape berries. J. Agric. Food Chem. 2006, 54, 6765-6775.
49. Robert, E. Adventures with GABA: Fifty Years On. In GABA in the Nervous System: The View at Fifty Years; Martin, D. L.; Olsen, R. W., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2000, pp. 1-24.
50. Florey, E. GABA: History and perspectives. Can. J. Physiol. Pharmacol. 1991, 69, 1049-1056.
51. Chapman, R. W.; Hey, J. A., Rizzo, C. A.; Bolser, D. C. GABAB receptors in the lung. Trends Pharmacol. Sci. 1993, 14, 26-29.